These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7811753)

  • 1. Certain properties of isoniazid inhibition of mycolic acid synthesis in cell-free systems of M. aurum and M. avium.
    Quémard A; Mazères S; Sut A; Lanéelle G; Lacave C
    Biochim Biophys Acta; 1995 Jan; 1254(1):98-104. PubMed ID: 7811753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.
    Quémard A; Lacave C; Lanéelle G
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1035-9. PubMed ID: 1656850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.
    Wheeler PR; Anderson PM
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):451-7. PubMed ID: 8809032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.
    Phetsuksiri B; Baulard AR; Cooper AM; Minnikin DE; Douglas JD; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1999 May; 43(5):1042-51. PubMed ID: 10223912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.
    Heym B; Cole ST
    Res Microbiol; 1992 Sep; 143(7):721-30. PubMed ID: 1488556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycolic acid synthesis: a target for ethionamide in mycobacteria?
    Quémard A; Lanéelle G; Lacave C
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1316-21. PubMed ID: 1416831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.
    Bardou F; Quémard A; Dupont MA; Horn C; Marchal G; Daffé M
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2459-67. PubMed ID: 8913447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium.
    Mdluli K; Swanson J; Fischer E; Lee RE; Barry CE
    Mol Microbiol; 1998 Mar; 27(6):1223-33. PubMed ID: 9570407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of catalases in Mycobacterium phlei on the basis of susceptibility to isoniazid: association with peroxidase and acquired resistance to isoniazid.
    Davis WB; Phillips DM
    Antimicrob Agents Chemother; 1977 Oct; 12(4):529-33. PubMed ID: 921249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in isoniazid susceptibility of Mycobacterium avium during the cell cycle.
    McCarthy CM
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):450-3. PubMed ID: 7224357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethylenic mycolic acid biosynthesis: extension of the biosynthetic model using cell-free extracts of Mycobacterium aurum and Mycobacterium smegmatis.
    Lopez-Marin LM; Quemard A; Laneelle G; Lacave C
    Biochim Biophys Acta; 1991 Oct; 1086(1):22-8. PubMed ID: 1954242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The katE gene, which encodes the catalase HPII of Mycobacterium avium.
    Milano A; De Rossi E; Gusberti L; Heym B; Marone P; Riccardi G
    Mol Microbiol; 1996 Jan; 19(1):113-23. PubMed ID: 8821941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PatA Regulates Isoniazid Resistance by Mediating Mycolic Acid Synthesis and Controls Biofilm Formation by Affecting Lipid Synthesis in Mycobacteria.
    Wang K; Deng Y; Cui X; Chen M; Ou Y; Li D; Guo M; Li W
    Microbiol Spectr; 2023 Jun; 11(3):e0092823. PubMed ID: 37212713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of isoniazid killing: clarity through the scope of genetics.
    Vilchèze C; Jacobs WR
    Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
    Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isonicotinic acid hydrazide induced changes and inhibition in mycolic acid synthesis in Nocardia and related taxa.
    Tomiyasu I; Yano I
    Arch Microbiol; 1984 Apr; 137(4):316-23. PubMed ID: 6428369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.
    Dhandayuthapani S; Zhang Y; Mudd MH; Deretic V
    J Bacteriol; 1996 Jun; 178(12):3641-9. PubMed ID: 8655566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
    Viader-Salvadó JM; Garza-González E; Valdez-Leal R; del Bosque-Moncayo MA; Tijerina-Menchaca R; Guerrero-Olazarán M
    J Clin Microbiol; 2001 Jul; 39(7):2642-5. PubMed ID: 11427584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between catalase activity, KatG gene and isoniazid-resistance in M. tuberculosis].
    Wang X; Han Q; Liang B
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar; 21(3):174-7. PubMed ID: 11263357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.